NORTHWESTERN UNIVERSITY IMAGE: CRYOEM IMAGE OF THE NOVEL CORONAVIRUS’ SPIKE PROTEIN CREDIT: NORTHWESTERN UNIVERSITY/WASHINGTON UNIVERSITY/UNIVERSITY OF WASHINGTON A new protein-based antiviral nasal spray developed by researchers at Northwestern University, University of Washington and Washington University at St. Louis is being advanced toward Phase I human clinical trials to treat COVID-19. Designed computationally and refined in...
Tag: <span>antibody treatments</span>
Post
New study suggests most monoclonal antibody treatments are ineffective against Omicron SARS-CoV-2 variant
By Jocelyn Solis-Moreira Dec 20 2021 Reviewed by Danielle Ellis, B.Sc. The arrival of the Omicron (B.1.1.529) variant has brought into question the effectiveness of current COVID-19 treatments in preventing infection and death. New research published in the preprint bioRxiv* server suggests the efficacy of most monoclonal antibody treatments are ineffective against Omicron. Since December 2019, the severe...